{ "schemaVersion": "deck-intelligence.v1", "id": "019dd923-622b-71dc-a6d9-a17d7f297d05", "slug": "f72bb77d31b3", "title": "Alexion Pharmaceuticals, Inc. (ALXN)", "subtitle": "Elliott · 2020-05", "author": "Elliott", "date": "2020-05-12 00:00:00", "pageCount": 10, "kind": "shareholder-letter", "orientation": "portrait", "aspectRatio": 0.7072243, "targetCompany": "Alexion Pharmaceuticals, Inc.", "targetTicker": "ALXN", "document": { "id": "019dd923-622b-71dc-a6d9-a17d7f297d05", "slug": "f72bb77d31b3", "title": "Alexion Pharmaceuticals, Inc. (ALXN)", "rawTitle": "alexion", "authorId": "02_Elliott_Management", "authorName": "Elliott", "authorDisplay": "Elliott", "kind": { "slug": "shareholder-letter", "label": "Shareholder letter" }, "sourceType": { "slug": "activist_investor", "label": "Activist investor" }, "fileName": "alexion.pdf", "sourceUrl": null, "sourceDate": "2020-05-12 00:00:00", "presentationDate": "2020-05-12 00:00:00", "ingestedAt": "2026-04-22 15:03:54+00", "status": "ready", "pageCount": 10, "orientation": "portrait", "aspectRatio": 0.7072243, "targetCompany": "Alexion Pharmaceuticals, Inc.", "targetTicker": "ALXN", "metadata": { "local_root": "/tmp/legacy-images/f72bb77d31b3", "activist_firm": "Elliott Advisors (UK) Limited", "origin_corpus": "contrarian", "extraction_seconds": 109.6308958530426 } }, "coverage": { "pageCount": 10, "pagesIndexed": 10, "pagesWithImages": 10, "pagesWithMetadata": 10, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 76, "chartCount": 4, "metricSlides": 0, "toolMatches": 7, "documentToolMatches": 3, "frameworkMatches": 7, "arcMatches": 1, "beatMatches": 3, "loopMatches": 1, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": false, "reviewAvailable": false, "activistThesisAvailable": true, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "evidence": "The sequence of slides follows a problem-agitate-solution narrative", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 21:53:50.951086+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 3, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 2, "name": "Problem", "beatId": "83dc7e47-222b-452a-8892-5d402c1dd0e4", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Problem (Identify pain)", "slug": "problem-agitate-solution-problem-identify-pain", "status": "active", "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131", "version": 1, "description": null }, "evidence": "Slides 2-3 identify the problem of underperformance", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 5, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 4, "name": "Agitate", "beatId": "d6d859ad-373c-42f4-84f9-3c0bbe2f6b61", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Agitate (Make it worse)", "slug": "problem-agitate-solution-agitate-make-it-worse", "status": "active", "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456", "version": 1, "description": null }, "evidence": "Slides 4-5 agitate the problem by highlighting missteps", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Development", "slug": "development", "status": "active", "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1", "version": 1, "description": "The middle stretch in arcs that have one. Often where length problems creep in." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 10, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 9, "name": "Solution", "beatId": "87e974c0-7c51-46ef-b4f3-96de5595f5ea", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Solution (Provide relief)", "slug": "problem-agitate-solution-solution-provide-relief", "status": "active", "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd", "version": 1, "description": null }, "evidence": "Slides 9-10 propose a solution and a call to action", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 9, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null, "categoryName": "Urgency", "categorySlug": "urgency" }, "matchId": "d6a31b16-0d81-4bff-93ce-68eda35c6530", "evidence": "Slide 8 implies the cost of inaction, slide 9 proposes a solution", "position": 0, "objective": "Highlight the cost of inaction", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:53:51.072975+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "Scenario planning", "slug": "scenario-planning", "status": "active", "bestFor": "Time horizon ≥12 months · ≥2 high-impact uncertainties that cannot be expressed as probability distributions · top two uncertainties roughly independent · team commits to revisit every 12–18 months. For shorter horizons use sensitivity analysis; for quantifiable risk use Monte Carlo; for one-dominant-uncertainty use cascade scenarios.", "canonId": "019de52d-1eb5-7639-abaa-44d7f65af562", "version": 1, "bodyDocId": "1b2fdf8f-9345-4d78-9875-7184e3da22ec", "description": "A structured way to think about the future when prediction is impossible. Build three to four distinct, internally-coherent stories of how the world could unfold, and stress-test strategy against each. The output is a set of named worlds the team can argue with — not a probability distribution.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "block", "agents": null, "matchId": "63961f88-9071-43b5-a53c-e1b62d487bf0", "evidence": "keyword-coverage: scenario, uncertainty", "pageRefs": [ 8 ], "priority": null, "whenToUse": "Time horizon ≥12 months · ≥2 high-impact uncertainties that cannot be expressed as probability distributions · top two uncertainties roughly independent · team commits to revisit every 12–18 months. For shorter horizons use sensitivity analysis; for quantifiable risk use Monte Carlo; for one-dominant-uncertainty use cascade scenarios.", "confidence": 0.2, "extraction": { "at": "2026-05-04 12:22:11.319774+00", "model": "keyword-backfill-v1", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": "Solves the two failure modes of forecasting at once: being precisely wrong (point estimates anyone can falsify) and uselessly hedged (ranges so wide they cannot guide action). Scenarios commit to a small set of plausible worlds and crystallise strategy into no-regret moves, sequenced bets, and lose-everywhere moves to drop. Names + early signals + wind-vane triggers turn the exercise into a usable contingency plan.", "antipattern": "Best/base/worst case (three points on one axis, not four scenarios) · probability-weighted average of scenarios (collapses to expected value) · Goldilocks-spaced scenarios that rank good-to-bad · scenarios named \"Scenario A/B/C\" instead of world-shape names · 50-row Excel labelled as a scenario (model, not story) · scenarios without measurable early signals.", "cardinality": null, "narrativePurpose": "Force narrative discipline on multi-year decisions where single-point forecasts fail. Translate structural uncertainty into a small set of decision frames the boardroom can act on by name." }, { "tool": { "name": "CEO quote contradiction", "slug": "ceo-quote-contradiction", "status": "active", "bestFor": "When management credibility is the lever", "canonId": "019dd9e1-52e9-717f-8454-93e627563ed6", "version": 1, "bodyDocId": "019dd9a1-8296-720d-8f51-da76937f9415", "description": "You reproduce management's own words — verbatim, with source and date — and\nthen place them next to the outcome that contradicts them. The CEO built\nthe rope; you put it around their own neck.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "document", "agents": null, "matchId": "68101a6d-04b8-482d-af0f-6ecaef78dca9", "evidence": null, "pageRefs": null, "priority": null, "whenToUse": "When management credibility is the lever", "confidence": null, "extraction": { "at": "2026-04-29 12:07:49.865912+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": null, "whyItWorks": "- **Maximum credibility**: no adjective you could write is as damning as the\n target's own prior statement.\n- **No rebuttal path**: management can't argue they didn't say it.\n- **It forces accountability onto a person**, not an institution — even if\n you aren't explicitly naming a villain elsewhere.\n- **Reporters amplify it**. A CEO-quote-contradiction slide is quotable,\n which means it lands in WSJ/FT/Bloomberg coverage.", "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Peer gap chart", "slug": "peer-gap", "status": "active", "bestFor": "When relative underperformance is the core argument", "canonId": "019dd9e1-54f1-775a-94a1-d5cf3bb75abf", "version": 1, "bodyDocId": "019dd9a1-8653-7748-9050-807f067196c3", "description": "A single visual that benchmarks the target against its best-in-class peers on\na single quantitative KPI — and shows the target losing. The gap is the\npunchline.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "document", "agents": null, "matchId": "b2392ffc-3985-41b3-9c30-35c46051af4d", "evidence": null, "pageRefs": null, "priority": null, "whenToUse": "When relative underperformance is the core argument", "confidence": null, "extraction": { "at": "2026-04-29 12:07:49.865912+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": null, "whyItWorks": "- It's the **most credible claim in the deck** because it's arithmetic, not\n opinion.\n- It's immediately **actionable** — close this gap and value accrues.\n- It **pre-empts the \"context is different\" defence** by pitting the target\n against direct peers in the same category.", "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Villain naming", "slug": "villain-naming", "status": "active", "bestFor": "When governance or specific decisions are the core thesis", "canonId": "019dd9e1-55a4-74db-9314-0ced4cd46cd2", "version": 1, "bodyDocId": "019dd9a1-88f1-72ad-8f4e-56ec29d7b369", "description": "You identify a **specific person** responsible for the target's underperformance\nor the behaviour you want changed — and name them. Not \"management\" or \"the\nboard\". A named executive or director with a specific failure attributable to\nthem.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "document", "agents": null, "matchId": "033cc736-b9f8-4bdc-8145-9f817375447d", "evidence": "David R. Brennan (Chairman) and the Alexion Board of Directors", "pageRefs": null, "priority": null, "whenToUse": "When governance or specific decisions are the core thesis", "confidence": null, "extraction": { "at": "2026-04-29 12:07:49.865912+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": null, "whyItWorks": "- **Accountability needs a face.** Voters (shareholders, regulators,\n journalists) act faster against people than institutions.\n- **Credibility rises with specificity.** \"The CFO has repeatedly missed\n guidance\" > \"Management has missed guidance\".\n- It **pre-empts evasion**. An individual can be removed; an abstraction\n cannot.\n- It **forces the target to respond personally** — and their defensive\n response usually generates more attention for your thesis.", "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Thesis: Activist defense (for management)", "slug": "activist-defense", "status": "active", "bestFor": null, "canonId": "019df269-16e3-7099-83d1-53afcc747cc6", "version": 1, "bodyDocId": "019df269-16b4-709a-9f8d-19d4cab4bea7", "description": "The mirror-image thesis. Management responding to an activist campaign,", "familyLabel": "thesis-archetype", "categoryName": "Competitive", "categorySlug": "competitive" }, "agent": "storyteller", "layer": "slide", "agents": [ "storyteller" ], "matchId": "48c04945-a42b-47a0-b6ba-ea0da172d258", "evidence": "However, the Portola announcement's profoundly negative impact on shareholder value – erasing approximately $1.7 billion from the Company's market capitalization in a single day – has led us to concl", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:47:36.486431+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Chart Selection Guide", "slug": "chart-selection-guide", "status": "active", "bestFor": null, "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae", "version": 1, "bodyDocId": null, "description": "Choosing the right chart type for your data and message", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Designer", "layer": "slide", "agents": [ "Designer" ], "matchId": "9a7442e8-a173-45b0-8f36-16ea672c7a28", "evidence": "chart/bar-vertical: Total Shareholder Return over ALXN Chairman Tenure (%)", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:47:36.616886+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 2, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Slide recipe: the peer-gap chart", "slug": "peer-gap-chart-recipe", "status": "active", "bestFor": null, "canonId": "019df269-2b04-75bc-ad85-e0179264bdd7", "version": 1, "bodyDocId": "019df269-2ae1-771d-9cd1-193a2e25f21c", "description": "The single most-copied slide in activism. This is the exact layout, used", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "4cde9d19-cbd4-462a-a4e4-0498e5582fa0", "evidence": "Indeed, during your tenure, Alexion is the worst performer across the broader large-cap biopharma sector.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:47:36.571763+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 2, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "9d8a8a8b-6431-4b4e-9068-762968b967bb", "evidence": "Comparing Alexion's performance against peers and indices to highlight underperformance.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 2, "frameworkName": "comparison_frame" }, { "matchId": "bf14c952-91be-41c5-ab40-12eb107f74ae", "evidence": "The slide explicitly lists negative market perceptions and past missteps to address them head-on.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "preempt_rebuttal" }, { "matchId": "b331147a-7ef0-4db0-a18f-1f118829ff8b", "evidence": "Contrasts stated M&A strategy with actual value destruction and analyst skepticism.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "expose_contradiction" }, { "matchId": "adebc14b-2ede-445d-a9ae-88bcacab30ee", "evidence": "Citing JPM, MS, and Stifel to validate the argument against management.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.921+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "frameworkName": "authority-citation" }, { "matchId": "42d2a0df-3f84-458a-9a58-f8393c6c58b7", "evidence": "Comparing peer forecast revenue growth to valuation multiples to identify mispricing.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "comparison_frame" }, { "matchId": "6429179f-1ba4-4bd6-b035-d367894a3642", "evidence": "Comparison to Copaxone 20mg/40mg switch to justify market share resilience.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "frameworkName": "argument-from-analogy" }, { "matchId": "542dabdb-45e8-4320-8f39-c0b018de79da", "evidence": "The slide systematically rejects status quo options and proposes a sale as the optimal solution.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.602+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "propose_solution" } ], "patterns": [] }, "storymakers": null, "score": null, "review": null, "activistThesis": { "tone": "mixed", "notes": "Public letter from Elliott Advisors (UK) to Alexion Chairman David Brennan, cc'd to Board and CEO Hantson. Elliott explicitly states it first made the sale recommendation privately in December 2019; the Portola announcement (5-May-2020, -7.3% one-day) prompted going public. No stake percentage disclosed in the letter itself. Signed by the firm (Elliott Advisors (UK) Limited), not by a named individual. Campaign outcome: Alexion was ultimately acquired by AstraZeneca in a deal announced December 2020 — Elliott won. Rhetoric is constructive-adversarial: praises Hantson's operational execution while demolishing Board credibility. Heavy use of sell-side analyst quotes (JPM, MS, Stifel, Jefferies, BAML, Evercore, RBC, Raymond James) to triangulate thesis. Standout visual: page 7 regression of EV/EBITDA vs. 5yr revenue CAGR with annotated circles separating pharma vs. biotech trading ranges.", "kpisCited": [ { "detail": "Over 75% reduction; now 6.1x 2021E, among lowest in large-cap biopharma", "metric": "EV/EBITDA multiple compression since 2015" }, { "detail": "-58% (1yr), -52% (2yr), -48% (3yr), -45% over Chair tenure", "metric": "Cumulative relative TSR vs. Proxy Peer Average" }, { "detail": "-20% for ALXN vs. +152% for SGEN, +135% VRTX, +103% LLY/AZN — worst in large-cap biopharma", "metric": "TSR over ALXN Chairman tenure" }, { "detail": "Achillion $1.2bn (166% of EV); Portola $1.7bn (137% of EV)", "metric": "Market value destroyed by recent deals" }, { "detail": "~2% at midpoint — sharp reversal from 'double-digit' ambition at 2019 Investor Day", "metric": "2020 EPS growth guidance" }, { "detail": "ALXN trades at ~50% discount to pharma players with the same growth rate", "metric": "Valuation vs. pharma peers" }, { "detail": "40% median upside for ALXN vs. 6% for large-cap biotech peers", "metric": "Sell-side target price upside" }, { "detail": "+11% increase, reflecting strong cost control under Hantson", "metric": "Operating margin improvement since 2017" }, { "detail": "43% CAGR 2016-19; expected to contribute 14% of 2020 sales", "metric": "Metabolic franchise growth" } ], "closingAsk": "We respectfully urge the Board to acknowledge the limitations of the current strategy and act with urgency in exploring strategic alternatives — i.e., sell the Company.", "extraction": { "at": "2026-04-22 15:03:54+00", "model": "unknown-legacy", "runId": null, "seconds": 109.6309, "promptVersion": null }, "scqaReward": "Sell-side analysts see ~40% median upside to fair value (vs. 6% for biotech peers); a strategic acquirer applying a large-cap pharma WACC of under 11% would crystallize a ~40-50% discount-to-fair-value gap plus synergies.", "thesisTypes": [ "sale_of_company", "governance_board", "strategic_pivot" ], "top3Reasons": [ "ALXN is the worst TSR performer in large-cap biopharma under Brennan's chairmanship", "Achillion and Portola deals destroyed $2.9bn — 137-166% of transaction EV", "ALXN trades at ~50% discount to pharma peers despite 8% CAGR and 55%+ EBITDA margins" ], "scqaSituation": "Alexion is a leading rare-disease biopharma with a world-class complement franchise (Soliris/Ultomiris), 55%+ EBITDA margins, $2bn+ annual FCF and IP protection through 2035 — fundamentally strong in a fundamentally strong industry.", "thesisSummary": "Elliott, a long-term Alexion holder since 2017, argues that despite strong operational execution under CEO Ludwig Hantson the market has rendered a decisive verdict against the 'go-it-alone' strategy: ALXN is the worst TSR performer in large-cap biopharma over Chairman Brennan's tenure, trailing the proxy peer average by 45-58% across one-, two- and three-year windows. A cascade of six missteps — capped by the Achillion and Portola acquisitions that destroyed $2.9bn of market value (137-166% of transaction EV) — has shattered investor trust. ALXN now trades at 6.1x 2021 EV/EBITDA, a ~50% discount to pharma peers, implying a negative five-year revenue CAGR versus management's double-digit ambition. With operational fixes, M&A, merger-of-equals and buybacks all judged inadequate, Elliott urges the Board to immediately explore a sale to close the ~40-50% gap to fair value.", "primaryDemands": [ "Immediately explore a sale of the Company to a strategic acquirer", "Acknowledge the limitations of the stand-alone strategy and act with urgency on strategic alternatives", "Refresh the Board with fresh perspectives following years of value destruction", "Halt further large-scale M&A, which would be viewed as an act of desperation" ], "scqaResolution": "The Board must immediately abandon the stand-alone strategy and explore a sale of the Company; operational tweaks, further M&A, a merger of equals and capital returns have all been evaluated and judged insufficient to restore confidence.", "thesisOneLiner": "Alexion's stand-alone strategy has failed — serial M&A missteps and a deep valuation discount mean the Board must pursue a sale now to unlock 40-50% upside for shareholders.", "precedentsCited": [ "Synageva acquisition (disastrous prior Alexion M&A)", "Copaxone / Teva 40mg generic switch (complement franchise defensibility analogue)" ], "scqaComplication": "Despite operational improvements since 2017, the market has priced in terminal decline: ALXN is the worst TSR performer in large-cap biopharma, and the Achillion and Portola deals destroyed $2.9bn, erasing 137-166% of transaction EV and shattering Board credibility.", "narrativeInterest": 5, "notableSlidePages": [ 1, 2, 3, 4, 7 ], "peerCompaniesCited": [ "INCY", "MRK", "BMRN", "SAN", "GSK", "BIIB", "BMY", "PFE", "GILD", "NOVN", "JNJ", "REGN", "ROG", "ABBV", "AMGN", "AZN", "LLY", "VRTX", "SGEN", "Biogen", "Biomarin", "Gilead", "Incyte", "Regeneron", "Seattle Genetics", "Vertex", "Amgen", "AstraZeneca", "BMS", "Eli Lilly", "GlaxoSmithKline", "J&J", "Merck", "Merck KGaA", "Novartis", "Pfizer", "Roche", "Sanofi" ], "valuationFrameworks": [ "multiple_comparison", "dcf", "precedent_transactions" ], "visualCraftInterest": 3 }, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "setup", "title": "This is a formal shareholder letter from Elliott Advisors to Alexion Pharmaceuticals, dated May 12, 2020.", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/70mvC6eSzDBP4k9Fbw76S0B3lUtlIaN3PQ6BxgV2mWA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mNzJiYjc3ZDMxYjMvcDAwMS5wbmc", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "dense", "densityScore": 54, "componentCount": 6, "textChars": 930, "nDataPoints": 1, "notes": "This is a formal shareholder letter from Elliott Advisors to Alexion Pharmaceuticals, dated May 12, 2020.", "elementsJson": [ "logo_grid", "paragraph", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:08.665+00", "seconds": 2.679, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/1", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-1", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "the best approach for the Company and its stakeholders is the immediate exploration of a sale, which, as explained below, would create significant upside for shareholders while creating a more stable footing for all those with a vested interest in Alexion's future – including its patients.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-cd07a5f0d236", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.3, "x": 0.35, "y": 0.05 }, "kind": "other", "text": "ELLIOTT ADVISORS (UK) LIMITED", "attrs": null, "canon": { "kind": { "name": "Other", "slug": "other", "status": "active", "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d", "version": 1, "description": "Fallback when no canonical kind applies." }, "tool": null, "subkind": { "name": "Unclassified", "slug": "unclassified", "status": "active", "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0", "version": 1, "description": null }, "framework": null }, "subkind": "unclassified", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:08.665+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "41ba8138-291d-4eba-9539-8633d629cc3c", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.45 }, "kind": "paragraph", "text": "A detailed review... led us to conclude last year that the best approach for the Company and its stakeholders is the immediate exploration of a sale.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:08.665+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "31ab8a0a-7a2f-45d8-91ec-d5a7e1973d7a", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.75 }, "kind": "paragraph", "text": "However, the Portola announcement's profoundly negative impact on shareholder value – erasing approximately $1.7 billion from the Company's market capitalization in a single day – has led us to conclude that a broader public discussion is necessary.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:08.665+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7c5b2256-bfc8-4714-8983-0138c6a1863b", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.25 }, "kind": "paragraph", "text": "On behalf of funds advised by Elliott... we are writing to share with you our latest perspectives on the Company's future.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:08.665+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "83248052-056a-4e8b-bfcf-9c9862f0309c", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.6, "x": 0.1, "y": 0.92 }, "kind": "source-note", "text": "Daily change in market capitalization, adjusted for iShares NASDAQ Biotechnology Index move", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:08.665+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fc1502cd-fd7f-43c3-9f73-a4a9ab9005df", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Thesis: Activist defense (for management)", "slug": "activist-defense", "status": "active", "bestFor": null, "canonId": "019df269-16e3-7099-83d1-53afcc747cc6", "version": 1, "bodyDocId": "019df269-16b4-709a-9f8d-19d4cab4bea7", "description": "The mirror-image thesis. Management responding to an activist campaign,", "familyLabel": "thesis-archetype", "categoryName": "Competitive", "categorySlug": "competitive" }, "agent": "storyteller", "layer": "slide", "agents": [ "storyteller" ], "matchId": "48c04945-a42b-47a0-b6ba-ea0da172d258", "evidence": "However, the Portola announcement's profoundly negative impact on shareholder value – erasing approximately $1.7 billion from the Company's market capitalization in a single day – has led us to concl", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:47:36.486431+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/NQr-7a6HMr1ounBsAxDicMXYHTdCeSUJ3ddlKBX39Wg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mNzJiYjc3ZDMxYjMvcDAwMS5wbmc", "imagePathAlt": "https://imgproxy.kitesheet.com/9MOsoL-E0XTbhUqkSfmbmj5xWXxsY4HjHb846hxgOLg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mNzJiYjc3ZDMxYjMvcDAwMS5qcGc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/tpa4qk4ShjpW3v9TmmcNojj_Iv3KUcW_iE5VH02V-Rk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mNzJiYjc3ZDMxYjMvcDAwMS5qcGc" }, { "page": 2, "type": "analysis", "title": "The slide uses a combination of a line chart for valuation erosion and bar charts for relative performance benchmarking.", "function": "expose_gap", "rawType": "peer_gap", "block": null, "metadata": { "slideType": "peer_gap", "slideTypeCanon": { "name": "Peer gap", "slug": "peer_gap", "status": "active", "canonId": "019de52d-10e5-74bd-8325-9f49c945a0aa", "version": 1, "description": null }, "function": "expose_gap", "functionCanon": { "name": "Expose gap", "slug": "expose_gap", "status": "active", "canonId": "019de52d-1795-772d-8f3a-75ccfb93fe58", "version": 1, "description": null }, "density": "dense", "densityScore": 61, "componentCount": 8, "textChars": 509, "nDataPoints": 36, "notes": "The slide uses a combination of a line chart for valuation erosion and bar charts for relative performance benchmarking.", "elementsJson": [ "headline_text", "paragraph", "line_chart", "bar_chart_grouped", "bar_chart_vertical", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:09.437+00", "seconds": 3.231, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/2", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-2", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Indeed, during your tenure, Alexion is the worst performer across the broader large-cap biopharma sector.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-a1bdd21470f6", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.82, "x": 0.09, "y": 0.41 }, "kind": "chart", "text": "Cumulative Relative Total Shareholder Returns (%)", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Grouped bar chart", "slug": "bar-grouped", "status": "active", "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1", "version": 1, "description": null }, "framework": null }, "subkind": "bar-grouped", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "98931e57-d7d8-4f9f-a834-7822b4c8c9a6", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.82, "x": 0.09, "y": 0.61 }, "kind": "chart", "text": "Total Shareholder Return over ALXN Chairman Tenure (%)", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b9af3e18-4966-4b75-aa6a-c99df9a18bbf", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.82, "x": 0.09, "y": 0.18 }, "kind": "chart", "text": "Alexion EV / EBITDA", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a7b2bed4-9452-4623-9752-05959a3addf6", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Total Shareholder Return: (20)%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-a570d7d5fbd0", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.82, "x": 0.09, "y": 0.11 }, "kind": "paragraph", "text": "Despite Alexion's attractive franchise and favorable operating performance, the Company's share price has persistently struggled over the last few years.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f8cc4099-8773-4c14-8583-44579f28c4e7", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.82, "x": 0.09, "y": 0.81 }, "kind": "source-note", "text": "Based on Bloomberg EV / FY1 EBITDA as of 8-May-2020...", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "226cc9f2-d92c-492c-9ac4-f71cf941538c", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.45, "x": 0.09, "y": 0.08 }, "kind": "title", "text": "Alexion Has Been a Persistent Underperformer", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "61ff07f3-727c-4da8-baa4-4150a3135cb8", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Chart Selection Guide", "slug": "chart-selection-guide", "status": "active", "bestFor": null, "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae", "version": 1, "bodyDocId": null, "description": "Choosing the right chart type for your data and message", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Designer", "layer": "slide", "agents": [ "Designer" ], "matchId": "9a7442e8-a173-45b0-8f36-16ea672c7a28", "evidence": "chart/bar-vertical: Total Shareholder Return over ALXN Chairman Tenure (%)", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:47:36.616886+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 2, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Slide recipe: the peer-gap chart", "slug": "peer-gap-chart-recipe", "status": "active", "bestFor": null, "canonId": "019df269-2b04-75bc-ad85-e0179264bdd7", "version": 1, "bodyDocId": "019df269-2ae1-771d-9cd1-193a2e25f21c", "description": "The single most-copied slide in activism. This is the exact layout, used", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "4cde9d19-cbd4-462a-a4e4-0498e5582fa0", "evidence": "Indeed, during your tenure, Alexion is the worst performer across the broader large-cap biopharma sector.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:47:36.571763+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 2, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "9d8a8a8b-6431-4b4e-9068-762968b967bb", "evidence": "Comparing Alexion's performance against peers and indices to highlight underperformance.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.437+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 2, "frameworkName": "comparison_frame" } ], "arcBeats": [ { "to": 3, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null }, "from": 2, "name": "Problem", "beatId": "83dc7e47-222b-452a-8892-5d402c1dd0e4", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Problem (Identify pain)", "slug": "problem-agitate-solution-problem-identify-pain", "status": "active", "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131", "version": 1, "description": null }, "evidence": "Slides 2-3 identify the problem of underperformance", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 3, "type": "setup", "title": "The slide uses a list of analyst quotes to frame the 'existential debate' and a table to quantify the impact of specific corporate missteps.", "function": "preempt_rebuttal", "rawType": "preempt_rebuttal", "block": null, "metadata": { "slideType": "preempt_rebuttal", "slideTypeCanon": { "name": "Preempt rebuttal", "slug": "preempt_rebuttal", "status": "active", "canonId": "019de52d-1225-7368-af32-6381fddabdb3", "version": 1, "description": null }, "function": "preempt_rebuttal", "functionCanon": { "name": "Preempt rebuttal", "slug": "preempt_rebuttal", "status": "active", "canonId": "019de52d-18ab-7479-9a7e-820a2f03586a", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 92, "componentCount": 10, "textChars": 2322, "nDataPoints": 18, "notes": "The slide uses a list of analyst quotes to frame the 'existential debate' and a table to quantify the impact of specific corporate missteps.", "elementsJson": [ "paragraph", "bullet_list", "data_table", "footnote" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:09.624+00", "seconds": 3.2, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/3", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-3", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Unfortunately, as we have highlighted to you throughout our engagement, this overhang cannot be addressed through incremental improvements to the business, with analysts repeatedly highlighting the inability of the market to look beyond the longevity debate and reward the substantial operational improvements that the Company has made over the last few years.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-18c5ff4edac3", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.79, "x": 0.12, "y": 0.43 }, "kind": "list", "text": "Analyst quotes regarding pipeline diversification, lowered guidance, and near-term catalyst path.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "312873bb-900b-4765-9669-a8839a57e6e7", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.79, "x": 0.12, "y": 0.2 }, "kind": "list", "text": "Analyst quotes regarding the existential nature of the investment debate and the C5 franchise strategy.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f611ba42-14c1-4535-95ec-79b9f2f6fcec", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "share price performance: (9.5)%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-2385461a29a0", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.82, "x": 0.09, "y": 0.35 }, "kind": "paragraph", "text": "Unfortunately, as we have highlighted to you throughout our engagement, this overhang cannot be addressed through incremental improvements to the business.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2b7a1de8-7eae-46f3-9485-9e57ec99868c", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.82, "x": 0.09, "y": 0.82 }, "kind": "paragraph", "text": "In all the examples above, Alexion’s attempts to reassure an already skittish investor base failed. The Company’s deficient communication more often than not left doubts unaddressed.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "78f28411-c772-42bd-bd09-1a5f10f76c87", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.82, "x": 0.09, "y": 0.09 }, "kind": "paragraph", "text": "Negative market sentiment continues to weigh heavily on Alexion’s share price. Significant skepticism has persisted with respect to the resilience and longevity of its complement franchise.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a7d30c52-8582-4e17-a4ef-f160cfcccd62", "parentComponentId": null }, { "bbox": null, "kind": "quote", "text": "\"One of the challenges we’ve had with ALXN shares has been the existential nature of the investment debate, and that the bull / bear discussion – even as management execution has been strong – seems largely focused on the stock's terminal value\" — Stifel, August 30, 2019; \"We expect ALXN to remain in its current trading range until there is greater visibility in the strategy beyond C5\" — MS, May 6, 2020; \"The shares are not expensive. However, we remain neutral given yet-to-be materialized success in pipeline diversification beyond the C5 franchise (~86% of revenue) & potential entry of competitors for the C5 franchise\" — Jefferies, May 6, 2020; \"Still, we think the lowered guidance will overshadow the 1Q results and along with persistent doubts about the longer-term future of the C5 franchise prior to competitor launches we would remain on the sidelines for now\" — BAML, May 6, 2020; \"We expect execution to remain strong, though the stock suffers from a so-so near term catalyst path, as well as a theoretical (hard-to-refute) bear case\" — Stifel, May 6, 2020.", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-1d304e3942db", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.5, "x": 0.09, "y": 0.91 }, "kind": "source-note", "text": "Event date share price performance vs. iShares NASDAQ Biotechnology Index", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "01257140-5727-455a-b85a-fa4537ee44a9", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.82, "x": 0.09, "y": 0.6 }, "kind": "table", "text": "Table of 6 events with dates and share performance impact.", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4575742c-f8c1-4f41-8e22-ad91edc5d107", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "bf14c952-91be-41c5-ab40-12eb107f74ae", "evidence": "The slide explicitly lists negative market perceptions and past missteps to address them head-on.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.624+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "preempt_rebuttal" } ], "arcBeats": [ { "to": 3, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null }, "from": 2, "name": "Problem", "beatId": "83dc7e47-222b-452a-8892-5d402c1dd0e4", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Problem (Identify pain)", "slug": "problem-agitate-solution-problem-identify-pain", "status": "active", "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131", "version": 1, "description": null }, "evidence": "Slides 2-3 identify the problem of underperformance", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 4, "type": "tension", "title": "Uses analyst quotes to highlight the gap between management's stated discipline and the market's perception of defensive, value-destroying M&A.", "function": "expose_contradiction", "rawType": "expose_contradiction", "block": null, "metadata": { "slideType": "expose_contradiction", "slideTypeCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 82, "componentCount": 9, "textChars": 1352, "nDataPoints": 8, "notes": "Uses analyst quotes to highlight the gap between management's stated discipline and the market's perception of defensive, value-destroying M&A.", "elementsJson": [ "paragraph", "bullet_list", "comparison_table", "footnote" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:09.806+00", "seconds": 3.375, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/4", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-4", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Yet the announcements of Alexion's acquisitions of Achillion and Portola both destroyed significant shareholder value.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-c6f5aaa3b3de", "parentComponentId": null }, { "bbox": { "h": 0.22, "w": 0.82, "x": 0.09, "y": 0.24 }, "kind": "list", "text": "Quotes from Aradhana Sarin (CFO), RBC Europe, and Stifel regarding the company's M&A strategy.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c913f54-0731-4076-8c03-273db704f2c5", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.82, "x": 0.09, "y": 0.74 }, "kind": "list", "text": "Quotes from Evercore ISI and Raymond James regarding the defensive nature of the Achillion transaction.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bc5fa31b-4288-48dd-8bea-5dd713390bcf", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Value Destruction as % EV: 166%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-ce9e2671dc66", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.82, "x": 0.09, "y": 0.65 }, "kind": "paragraph", "text": "It is possible to argue that Achillion provides a coherent strategic fit... Yet Alexion failed to appreciate the appearance of defensiveness in the timing and communication around this transaction.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0a2d66b2-9422-448d-9d6f-e970d0298393", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.82, "x": 0.09, "y": 0.18 }, "kind": "paragraph", "text": "Two of the most instructive missteps listed above include the recent acquisitions of Achillion and Portola, which highlight the degree to which the Company is at odds with market expectations.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "392d1506-97a9-4ba0-a345-5f84901ca111", "parentComponentId": null }, { "bbox": null, "kind": "quote", "text": "\"Our acquisition strategy has really been focused on rebuilding our pipeline over the last 2 years [...] our plan is still to keep rebuilding that pipeline, continue the path that we are on from a diversification standpoint, and most importantly, sort of stay disciplined on matching the risk that we take with a particular BD or partnership or license or acquisition with the value that we pay for it\" — Aradhana Sarin, CFO, March 3, 2020", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-caca9cdc44f9", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.82, "x": 0.09, "y": 0.85 }, "kind": "source-note", "text": "Footnotes 8-12 detailing sources for quotes and data.", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7cf6e9cc-7cd7-4fa8-9195-32b8f2253ad4", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.6, "x": 0.2, "y": 0.51 }, "kind": "table", "text": "Table showing Transaction EV, Relative Perf, Market Value Destroyed, and Value Destruction as % EV for Achillion and Portola.", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2603cff6-5872-44fb-950a-e0e4285b0cc0", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "b331147a-7ef0-4db0-a18f-1f118829ff8b", "evidence": "Contrasts stated M&A strategy with actual value destruction and analyst skepticism.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.806+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "expose_contradiction" } ], "arcBeats": [ { "to": 5, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null }, "from": 4, "name": "Agitate", "beatId": "d6d859ad-373c-42f4-84f9-3c0bbe2f6b61", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Agitate (Make it worse)", "slug": "problem-agitate-solution-agitate-make-it-worse", "status": "active", "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456", "version": 1, "description": null }, "evidence": "Slides 4-5 agitate the problem by highlighting missteps", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Development", "slug": "development", "status": "active", "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1", "version": 1, "description": "The middle stretch in arcs that have one. Often where length problems creep in." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 5, "type": "tension", "title": "The slide uses external analyst quotes to build a case against management's M&A strategy.", "function": "name_villain", "rawType": "villain_critique", "block": null, "metadata": { "slideType": "villain_critique", "slideTypeCanon": { "name": "Villain critique", "slug": "villain_critique", "status": "active", "canonId": "019de52d-10bc-7136-bf20-09de59d17447", "version": 1, "description": null }, "function": "name_villain", "functionCanon": { "name": "Name villain", "slug": "name_villain", "status": "active", "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526", "version": 1, "description": null }, "density": "dense", "densityScore": 63, "componentCount": 6, "textChars": 1720, "nDataPoints": 1, "notes": "The slide uses external analyst quotes to build a case against management's M&A strategy.", "elementsJson": [ "paragraph", "bullet_list", "quote_block" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:09.921+00", "seconds": 3.347, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/5", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-5", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Such a disproportionate decline in a company's share price is the sign of much deeper concerns regarding a company's perceived strategy.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-fadac27fe1cf", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.8, "x": 0.1, "y": 0.35 }, "kind": "list", "text": "Analyst quotes from JPM, MS, and Stifel expressing skepticism regarding the Portola acquisition.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.921+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "89713e33-852b-4f4d-a23f-02333010f63c", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.8, "x": 0.1, "y": 0.08 }, "kind": "paragraph", "text": "Likely bruised by the market's reaction to this first business development initiative, Alexion nonetheless went on to announce the acquisition of Portola...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.921+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8e1df0dd-5d9e-4e75-81ed-0eda88338c2b", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.8, "x": 0.1, "y": 0.72 }, "kind": "paragraph", "text": "The above assessment of the untenable status quo is especially frustrating given both the Company's underlying strengths...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.921+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a9f82bbc-86c1-4d28-b167-067bdc1e6918", "parentComponentId": null }, { "bbox": null, "kind": "quote", "text": "\"Buying a Biotech on the Cheap Not Helping to Restore Investor Sentiment ... While we expected ALXN would remain active on the BD front, we were surprised to see it go after a beaten down story ... Portola's early commercial struggles will likely induce skepticism that today's deal can meaningfully diversify ... accordingly, client feedback on the deal has been mixed at best\" — JPM, May 5, 2020; \"Portola acquisition provides mgt. with an additional revenue generating product, but at a high initial cost... [ALXN] has no cardiovascular exposure, is acquiring a product that has struggled for multiple years given narrow utilization criteria and mgt. is paying a 12.5x trailing revenue multiple ... we expect a material earning contribution to take time\" — MS, May 5, 2020; \"From our discussions with investors we've heard almost universally negative feedback on this deal, ranging from concerns that Andexxa could be over-priced (a reason behind weak initial uptake/reimbursement), to broader reservations surrounding ALXN levering itself to a hospital-based product in the midst of an ongoing pandemic\" — Stifel, May 6, 2020", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-fdec348de654", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.1, "y": 0.65 }, "kind": "title", "text": "Self-Reinforcing Underperformance is Obscuring the Attractiveness of the Company", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.921+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "042b992d-3367-413f-a3cb-129318cb20c9", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "adebc14b-2ede-445d-a9ae-88bcacab30ee", "evidence": "Citing JPM, MS, and Stifel to validate the argument against management.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.921+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "frameworkName": "authority-citation" } ], "arcBeats": [ { "to": 5, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null }, "from": 4, "name": "Agitate", "beatId": "d6d859ad-373c-42f4-84f9-3c0bbe2f6b61", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Agitate (Make it worse)", "slug": "problem-agitate-solution-agitate-make-it-worse", "status": "active", "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456", "version": 1, "description": null }, "evidence": "Slides 4-5 agitate the problem by highlighting missteps", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Development", "slug": "development", "status": "active", "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1", "version": 1, "description": "The middle stretch in arcs that have one. Often where length problems creep in." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 6, "type": "setup", "title": "This is a text-heavy page from a shareholder letter, likely part of a larger argument regarding management performance.", "function": "summarize", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "dense", "densityScore": 69, "componentCount": 7, "textChars": 1241, "nDataPoints": 8, "notes": "This is a text-heavy page from a shareholder letter, likely part of a larger argument regarding management performance.", "elementsJson": [ "paragraph", "bullet_list", "footnote" ], "confidence": 0.9, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:09.931+00", "seconds": 3.187, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/6", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-6", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "By all key operating measures, Dr. Hantson and his team have taken meaningful steps to improve the business during his relatively short tenure.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-804346e8afb9", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.8, "x": 0.1, "y": 0.55 }, "kind": "list", "text": "Long runway of volume-driven revenue growth (gMG, NMOSD, metabolic franchise 43% CAGR, pipeline with $3.7B peak risked revenues); Strong commercial positioning (patient loyalty, OneSource, KOL relationships).", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.931+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3fab17e4-3f2a-4a91-bbfb-671500a2e2d6", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.8, "x": 0.1, "y": 0.25 }, "kind": "list", "text": "Strong cost controls delivering an 11% increase in operating margins since 2017; Measured and sensible capital deployment strategy; Improved governance; Well-managed market expectations with 12/13 revenue beats and 13/13 EPS beats.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.931+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7c85981f-9d82-47af-9ffc-609968124d7e", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.4 }, "kind": "paragraph", "text": "In addition and more importantly, the Company succeeded in obtaining the approval of ALXN1210, now Ultomiris, and launching its commercialization.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.931+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "09dc980b-9f83-4b60-835b-67d75b14d97e", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.1 }, "kind": "paragraph", "text": "As we have referenced previously, when Dr. Ludwig Hantson joined as CEO in early 2017, Alexion was in a period of significant turmoil and uncertainty.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.931+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "84963e0f-0497-494a-a16e-5d1ff443ee7f", "parentComponentId": null }, { "bbox": null, "kind": "quote", "text": "of our engagement, Elliott has been extremely complimentary of our Board, management team and business. We appreciate Elliott’s recognition of the uniqueness and strength of Alexion’s business.” — Alexion Pharmaceuticals", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-86d6335c680e", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.4, "x": 0.1, "y": 0.85 }, "kind": "source-note", "text": "13 Based on FY2019A operating margins; 14 Based on Bloomberg consensus; 15 Based on the midpoint of 2020 guidance; 16 Based on Elliott analysis", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.931+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "539cea87-53af-487c-815f-90a21559547d", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 7, "type": "analysis", "title": "The slide uses a scatter plot to demonstrate that Alexion is undervalued compared to its peers with similar growth profiles.", "function": "expose_gap", "rawType": "peer_gap", "block": null, "metadata": { "slideType": "peer_gap", "slideTypeCanon": { "name": "Peer gap", "slug": "peer_gap", "status": "active", "canonId": "019de52d-10e5-74bd-8325-9f49c945a0aa", "version": 1, "description": null }, "function": "expose_gap", "functionCanon": { "name": "Expose gap", "slug": "expose_gap", "status": "active", "canonId": "019de52d-1795-772d-8f3a-75ccfb93fe58", "version": 1, "description": null }, "density": "dense", "densityScore": 69, "componentCount": 8, "textChars": 851, "nDataPoints": 15, "notes": "The slide uses a scatter plot to demonstrate that Alexion is undervalued compared to its peers with similar growth profiles.", "elementsJson": [ "paragraph", "bullet_list", "scatter_plot", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:10.224+00", "seconds": 3.175, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/7", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-7", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "ALXN trades at a ~50% discount to pharma players with the same growth rate", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-fba317106969", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.8, "x": 0.1, "y": 0.43 }, "kind": "chart", "text": "Scatter plot showing EV/EBITDA vs 5yr Rev CAGR for Large cap pharma and Large cap biotech, with Alexion Consensus and Management Ambition points.", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Scatter plot", "slug": "scatter", "status": "active", "canonId": "019de52d-007d-72ec-8689-c79fb78e21a2", "version": 1, "description": null }, "framework": null }, "subkind": "scatter", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1d117b08-8fac-40ff-afc0-83f3ee354f16", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "EV / EBITDA: 6.1x", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-ff62a2715bed", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.8, "x": 0.1, "y": 0.32 }, "kind": "paragraph", "text": "The Company benefits from a highly attractive financial profile... Alexion is expected to underperform its five-year consensus revenue CAGR by over 8%, in our view a highly unlikely scenario:", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "66321ad6-edbe-4e30-bc7e-a8e0c1929874", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.8, "x": 0.1, "y": 0.23 }, "kind": "paragraph", "text": "Our assessment of the relevant competitive landscape... has informed our conviction that Alexion's strengths and sustainable positioning are highly underappreciated...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "751d108e-1a2a-4b4b-ad9d-d44820f7bd38", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.8, "x": 0.1, "y": 0.08 }, "kind": "paragraph", "text": "Strong payor value proposition: Ultomiris offers meaningfully lower cost for payors... A highly profitable and cash-generative business...", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9d6fa732-9ea7-4d4c-85c5-66ae4b50fd7c", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.8, "x": 0.1, "y": 0.75 }, "kind": "source-note", "text": "17-22: Footnotes detailing data sources, assumptions, and peer group definitions.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2264bb2f-391c-4625-8376-44cbf856b390", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.4, "x": 0.1, "y": 0.41 }, "kind": "title", "text": "2020E EV / EBITDA vs. 5yr Revenue CAGR", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "468cfe78-c662-4b96-ae0c-14a20497f1fb", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "42d2a0df-3f84-458a-9a58-f8393c6c58b7", "evidence": "Comparing peer forecast revenue growth to valuation multiples to identify mispricing.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:10.224+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "comparison_frame" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 8, "type": "setup", "title": "This is a page from a shareholder letter, likely from Elliott Management, arguing for a sale of Alexion.", "function": "present_solution", "rawType": "thesis_headline", "block": null, "metadata": { "slideType": "thesis_headline", "slideTypeCanon": { "name": "Thesis headline", "slug": "thesis_headline", "status": "active", "canonId": "019de52d-073a-70cb-b9f6-772a597bb5af", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 84, "componentCount": 10, "textChars": 1271, "nDataPoints": 8, "notes": "This is a page from a shareholder letter, likely from Elliott Management, arguing for a sale of Alexion.", "elementsJson": [ "paragraph", "footnote" ], "confidence": 0.9, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:11.122+00", "seconds": 4.056, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/8", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-8", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "we believe Alexion shares now trade at a 40-50% discount to fair value.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-b7461c848828", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "valuation discount: 40-50%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-b865ff9b25e6", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.33 }, "kind": "paragraph", "text": "A company that possesses the aforementioned strengths yet trades at such a deep discount offers a highly attractive profile for a potential acquirer.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "24d9b7e4-3711-4b2f-9d30-7f610abe7305", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.45 }, "kind": "paragraph", "text": "Alexion provides a number of pharmaceutical companies with a unique value proposition... Alexion represents a highly strategic asset for any such player.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3847ff94-ffd0-4f73-a768-858318b4b911", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.8, "x": 0.1, "y": 0.79 }, "kind": "paragraph", "text": "While there is plenty of wider market uncertainty today, there is no doubt that the public market has not been hospitable to Alexion in any recent environment.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "45004562-8ea4-464f-9e2f-f2e747f0f046", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.8, "x": 0.1, "y": 0.57 }, "kind": "paragraph", "text": "Further, an acquisition would be very financially attractive... Alexion is highly cash generative, with c. 60% of current market capitalization expected to be generated in FCF organically over the next five years.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4bf0b045-d424-4c42-a1bf-83ca35d8aba2", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.8, "x": 0.1, "y": 0.08 }, "kind": "paragraph", "text": "Even based on conservative estimates... we believe Alexion shares now trade at a 40-50% discount to fair value.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7e19def1-79a3-46b2-8173-5591b0f67de1", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.8, "x": 0.1, "y": 0.18 }, "kind": "paragraph", "text": "Indeed, based on our analysis, the current market value ascribed to Alexion suggests that investors expect the Company’s core complement franchise market share to decline to less than 30%... In our view, this is a highly implausible scenario.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "87d4e1d5-a3e2-409f-8db5-cd1aa32df5ab", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.1, "y": 0.88 }, "kind": "source-note", "text": "23-26: Data sources including Bloomberg, DCF assumptions, and IMS Trx data.", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b9d9f8e2-8fec-4fa0-a967-2aef64487fe7", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.8, "x": 0.1, "y": 0.75 }, "kind": "title", "text": "Investor Patience Has Eroded, and Available Pathways Forward Are Limited", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2d951cb8-43e7-443d-b1db-1fe82f89630a", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Scenario planning", "slug": "scenario-planning", "status": "active", "bestFor": "Time horizon ≥12 months · ≥2 high-impact uncertainties that cannot be expressed as probability distributions · top two uncertainties roughly independent · team commits to revisit every 12–18 months. For shorter horizons use sensitivity analysis; for quantifiable risk use Monte Carlo; for one-dominant-uncertainty use cascade scenarios.", "canonId": "019de52d-1eb5-7639-abaa-44d7f65af562", "version": 1, "bodyDocId": "1b2fdf8f-9345-4d78-9875-7184e3da22ec", "description": "A structured way to think about the future when prediction is impossible. Build three to four distinct, internally-coherent stories of how the world could unfold, and stress-test strategy against each. The output is a set of named worlds the team can argue with — not a probability distribution.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "block", "agents": null, "matchId": "63961f88-9071-43b5-a53c-e1b62d487bf0", "evidence": "keyword-coverage: scenario, uncertainty", "pageRefs": [ 8 ], "priority": null, "whenToUse": "Time horizon ≥12 months · ≥2 high-impact uncertainties that cannot be expressed as probability distributions · top two uncertainties roughly independent · team commits to revisit every 12–18 months. For shorter horizons use sensitivity analysis; for quantifiable risk use Monte Carlo; for one-dominant-uncertainty use cascade scenarios.", "confidence": 0.2, "extraction": { "at": "2026-05-04 12:22:11.319774+00", "model": "keyword-backfill-v1", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": "Solves the two failure modes of forecasting at once: being precisely wrong (point estimates anyone can falsify) and uselessly hedged (ranges so wide they cannot guide action). Scenarios commit to a small set of plausible worlds and crystallise strategy into no-regret moves, sequenced bets, and lose-everywhere moves to drop. Names + early signals + wind-vane triggers turn the exercise into a usable contingency plan.", "antipattern": "Best/base/worst case (three points on one axis, not four scenarios) · probability-weighted average of scenarios (collapses to expected value) · Goldilocks-spaced scenarios that rank good-to-bad · scenarios named \"Scenario A/B/C\" instead of world-shape names · 50-row Excel labelled as a scenario (model, not story) · scenarios without measurable early signals.", "cardinality": null, "narrativePurpose": "Force narrative discipline on multi-year decisions where single-point forecasts fail. Translate structural uncertainty into a small set of decision frames the boardroom can act on by name." } ], "frameworks": [ { "matchId": "6429179f-1ba4-4bd6-b035-d367894a3642", "evidence": "Comparison to Copaxone 20mg/40mg switch to justify market share resilience.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 21:16:11.122+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "frameworkName": "argument-from-analogy" } ], "arcBeats": [], "loops": [ { "to": 9, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "d6a31b16-0d81-4bff-93ce-68eda35c6530", "evidence": "Slide 8 implies the cost of inaction, slide 9 proposes a solution", "position": 0, "objective": "Highlight the cost of inaction", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:53:51.072975+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 9, "type": "setup", "title": "This is a page from an activist investor letter (Elliott Management) to the Board of Alexion Pharmaceuticals.", "function": "propose_solution", "rawType": "propose_solution", "block": null, "metadata": { "slideType": "propose_solution", "slideTypeCanon": { "name": "Propose solution (contrarian)", "slug": "propose_solution", "status": "active", "canonId": "019de52d-1274-703c-81c6-5550f451697b", "version": 1, "description": null }, "function": "propose_solution", "functionCanon": { "name": "Propose solution (contrarian)", "slug": "propose_solution", "status": "active", "canonId": "019de52d-185b-74e9-bdfd-ea8cf318563f", "version": 1, "description": null }, "density": "balanced", "densityScore": 45, "componentCount": 5, "textChars": 878, "nDataPoints": 1, "notes": "This is a page from an activist investor letter (Elliott Management) to the Board of Alexion Pharmaceuticals.", "elementsJson": [ "paragraph", "bullet_list" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:09.602+00", "seconds": 2.446, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/9", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-9", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Selling the Company is the best and (at this point) the most viable pathway forward to solve its prolonged market issues and deliver an optimal outcome to all with a stake in Alexion’s future.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:07+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5ba-51815c54a291", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.8, "x": 0.1, "y": 0.32 }, "kind": "list", "text": "Operational improvements? ... Diversification through M&A? ... Merger? ... Capital returns?", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.602+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b443c4c1-1d63-4582-b43b-5e80c7ca7068", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.8, "x": 0.1, "y": 0.09 }, "kind": "paragraph", "text": "coupled with an escalating series of missteps have eroded trust in the Board and management and have obscured the attractiveness of the franchise.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.602+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0eabf702-85c8-47eb-a77e-3b78b3d8fa48", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.8, "x": 0.1, "y": 0.88 }, "kind": "paragraph", "text": "We respectfully urge the Board to acknowledge the limitations of the current strategy in light of the Company's persistent underperformance and to act with urgency in exploring strategic alternatives.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.602+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "52642286-2e69-4024-b2ee-aec7d0b7db8a", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.8, "x": 0.1, "y": 0.78 }, "kind": "paragraph", "text": "Having spent the last several years deeply engaged with Alexion... we return to the same conclusion: Alexion is a great company, but cannot reach its full potential as a listed stand-alone company. Selling the Company is the best... pathway forward.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:09.602+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "559b469c-4979-4bd8-ab94-ef2b96f439fe", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "542dabdb-45e8-4320-8f39-c0b018de79da", "evidence": "The slide systematically rejects status quo options and proposes a sale as the optimal solution.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 21:16:09.602+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "propose_solution" } ], "arcBeats": [ { "to": 10, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null }, "from": 9, "name": "Solution", "beatId": "87e974c0-7c51-46ef-b4f3-96de5595f5ea", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Solution (Provide relief)", "slug": "problem-agitate-solution-solution-provide-relief", "status": "active", "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd", "version": 1, "description": null }, "evidence": "Slides 9-10 propose a solution and a call to action", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 9, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "d6a31b16-0d81-4bff-93ce-68eda35c6530", "evidence": "Slide 8 implies the cost of inaction, slide 9 proposes a solution", "position": 0, "objective": "Highlight the cost of inaction", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:53:51.072975+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 10, "type": "setup", "title": "This is the final page of a formal activist investor letter.", "function": "closing_ask", "rawType": "closing_ask", "block": null, "metadata": { "slideType": "closing_ask", "slideTypeCanon": { "name": "Closing ask", "slug": "closing_ask", "status": "active", "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c", "version": 1, "description": null }, "function": "closing_ask", "functionCanon": { "name": "Closing ask (contrarian)", "slug": "closing_ask", "status": "active", "canonId": "019de52d-18d2-7137-8c99-0a14eb350f0f", "version": 1, "description": null }, "density": "dense", "densityScore": 67, "componentCount": 7, "textChars": 1854, "nDataPoints": 0, "notes": "This is the final page of a formal activist investor letter.", "elementsJson": [ "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 21:16:10.285+00", "seconds": 3.036, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622b-71dc-a6d9-a17d7f297d05/10", "deck": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05", "deckAnchor": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05#slide-10", "deckJson": "/decks/019dd923-622b-71dc-a6d9-a17d7f297d05.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "We strongly encourage fresh thinking and bold action without further delay.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-23 02:35:06+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-78b5-7512-b5b9-eb96d6498193", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.8, "x": 0.1, "y": 0.45 }, "kind": "paragraph", "text": "We look forward to your response, and as always, we would be happy to answer any questions that you have as they pertain to this letter. We remain hopeful that we can work together now as we have in the past to advance the best interests of the Company and its stakeholders.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.285+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0fb7de99-3266-4cfc-923a-ed841ffeea83", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.6, "x": 0.1, "y": 0.62 }, "kind": "paragraph", "text": "Cc: Alexion Board of Directors, Alexion CEO Dr. Ludwig Hantson", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.285+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "678a8d9b-a1f5-4987-aa8d-3510fa32b1e6", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.8, "x": 0.1, "y": 0.13 }, "kind": "paragraph", "text": "The events of recent months have strengthened the case. Late last year, you insisted that Alexion simply needed more time to prove that its strategy was sufficient to turn things around. Since then, Alexion has continued to disappoint investors with its persistent share-price underperformance and further missteps. At the same time, the quick stock-market recovery from the March crash and the growing strength of pharmaceutical markets have bolstered the prospects of a win-win transaction. There are healthy acquirers who would benefit immensely from acquiring a company of Alexion's strength and profile.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.285+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b4795a84-c7ae-4439-a3a8-1f9c8abed58e", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.3, "x": 0.1, "y": 0.55 }, "kind": "paragraph", "text": "Sincerely,\n\nElliott Advisors (UK) Limited", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.285+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c029460f-22ef-4a3d-a275-7fb9aa73aa8a", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.8, "x": 0.1, "y": 0.29 }, "kind": "paragraph", "text": "Alexion's Board has overseen significant and consistent value destruction for shareholders over many years. Those who continue to cling to a failed strategy do not make a compelling case that they are best fit to steer Alexion into the future. Just as the Board has struggled to defend its current strategy given these suboptimal results, we anticipate that you and many of your fellow Board members will struggle to defend your track records when asking shareholders to support your continued service on the Board in the future. We strongly encourage fresh thinking and bold action without further delay.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.285+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d942c54d-f0b3-41d9-9256-92dc23cd05b1", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.1, "y": 0.08 }, "kind": "paragraph", "text": "Company, but those improvements have not gotten to the core challenge of the market's concerns. We first made this case to you only after a thorough consideration of all other alternatives.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 21:16:10.285+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fdafa0fa-cece-4363-9f2d-213b63153c2b", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "Problem-Agitate-Solution", "slug": "problem-agitate-solution", "status": "active", "bestFor": "Sales pitches, urgency-driven, competitive displacement", "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)", "description": null, "familyLabel": null }, "from": 9, "name": "Solution", "beatId": "87e974c0-7c51-46ef-b4f3-96de5595f5ea", "matchId": "e0d29d8a-a8d8-47ec-85d5-58f07cef7cdb", "beatType": { "name": "Solution (Provide relief)", "slug": "problem-agitate-solution-solution-provide-relief", "status": "active", "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd", "version": 1, "description": null }, "evidence": "Slides 9-10 propose a solution and a call to action", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true } ], "arcBeats": [ { "from": 2, "to": 3, "label": "Problem", "description": "Slides 2-3 identify the problem of underperformance" }, { "from": 4, "to": 5, "label": "Agitate", "description": "Slides 4-5 agitate the problem by highlighting missteps" }, { "from": 9, "to": 10, "label": "Solution", "description": "Slides 9-10 propose a solution and a call to action" } ], "loops": [ { "from": 8, "to": 9, "label": "Cost Of Inaction", "description": "Highlight the cost of inaction" } ] }